Nobuki Matsunami
Yamaguchi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).
Journal: Breast cancer research and treatment
Published: June 29, 2021
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
Journal: Investigational new drugs
Published: July 23, 2020
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.
Journal: Breast cancer research and treatment
Published: November 25, 2019
Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.
Journal: Japanese journal of clinical oncology
Published: March 12, 2019
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: March 08, 2019
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).
Journal: Cancer chemotherapy and pharmacology
Published: January 16, 2018
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes.
Journal: Cancer chemotherapy and pharmacology
Published: November 10, 2017
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
Journal: Breast cancer (Tokyo, Japan)
Published: August 31, 2017
A Case of Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Treated with TAS-102 with Bevacizumab
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 31, 2017
A Case of Multiple Pancreatic Metastases from Renal Cell Carcinoma Diagnosed Using EUS-FNA
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 31, 2017
Last Updated: 09/26/2026